Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Trauma (Emergency, Injury, Surgery) | Cardiology/Vascular Diseases
Disease Category: Surgery
Location: United States, FL
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery
1) To compare the efficacy of bridging anticoagulation (therapeutic-dose LMWH) with no bridging anticoagulation (placebo) on the rate of ATE in patients with atrial fibrillation or atrial flutter who require temporary interruption of warfarin.
2) To compare the safety of bridging anticoagulation with no bridging anticoagulation on the rate of major bleeding in patients who require temporary interruption of warfarin
Patient Inclusion Criteria:
Inclusion criteria - All of the following 5 criteria must be satisfied for trial eligibility:
Patient Exclusion Criteria:
One or more of the following criteria precludes trial eligibility:
CW ID: 180073
Date Last Changed:
July 19, 2013
Charles Russo, MD (HCH Site); Ricky Schneider, MD (Coral Springs Site)Holy Cross Jim Moran Heart and Vascular Research Institute1951 NE 47th StreetFort Lauderdale, FL 33308Phone: (954) 229-8400Fax: (954) 229-8597
Holy Cross Jim Moran Heart and Vascular Research Institute
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.